Tag: PrEP Implant

Early clinical trials by Merck are showing promise for a pre-exposure prophylaxis (PrEP) implant that could last up to a year. The move could be “game-changing” for those who use PrEP to halt HIV transmission.  The results were presented at the International AIDS Society (IAS) Conference on HIV Science. “I think the implant study is potentially game-changing,” said Anthony Fauci, MD, the director of the National Institute of Allergy and Infectious Diseases (NIAID), to MedPage Today. “The real problem with PrEP is,...